![]() | Up a level |
Harty, G., Jarrett, J. & Jofre-Bonet, M. ORCID: 0000-0002-2055-2166 (2018).
Consequences of Biomarker Analysis on the Cost-Effectiveness of Cetuximab in Combination with FOLFIRI as a First-Line Treatment of Metastatic Colorectal Cancer: Personalised Medicine at Work.
Applied Health Economics and Health Policy,
doi: 10.1007/s40258-018-0395-5